Register Login

ORGANON & CO. (OGN)

Falcione Aaron 🟡 adjusted position in 160.8K shares (3 derivative) of Organon & Co. (OGN) at $5.70 Transaction Date: Mar 31, 2026 | Filing ID: 023150

Full text
Register to leave comments
  • News bot April 2, 2026, 8:12 p.m.

    🔍 Falcione Aaron (Executive)

    Company: Organon & Co. (OGN)

    Report Date: 2026-03-31

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 184,869
    • Total shares sold: 24,065

    Detailed Transactions and Holdings:

    • Acquired 6,732 shares of Common Stock (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 96,378.07 | transaction_form_type: 4
    • Sold 2,306 shares of Common Stock at $5.7 per share (Direct)
      Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 94,072.07 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 11,193 shares of Common Stock (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 105,265.07 | transaction_form_type: 4
    • Sold 3,834 shares of Common Stock at $5.7 per share (Direct)
      Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 101,431.07 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 166,944 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 166,944.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2
    • Sold 6,732 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4, F4
    • Sold 11,193 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 22,386.00 | transaction_form_type: 4 | Footnotes: F3, F5, F5

    Footnotes:

    • F1: The price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
    • F2: On March 31, 2026, the Reporting Person was granted 166,944 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
    • F3: Each RSU represents a contingent right to receive one share of Organon common stock.
    • F4: On March 31, 2023, the Reporting Person was granted 20,195 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026.
    • F5: On March 31, 2025, the Reporting Person was granted 33,579 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining to vest on March 31, 2027 and March 31, 2028.

Search

News categories